According to the patient Kaplan Meier survival analysis based on CADM3 expression, BC patients with low CADM3 level had shorter OS, DFS and metastasis-free survival (MFS) (Fig. 2E-G), which was consistent with the results of the TCGA database prediction. The gene discussed is CADM3; the disease is breast cancer.